ctrl K

Price Alert

Adial Pharmaceuticals Inc... (ADILW)

NASDAQ: ADILW · Real-Time Price · USD

0.00

-0.00 (-100.00%)

At close: Jul 27, 2023, 9:52 PM

Adial Pharmaceuticals WT EXP 073123 Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.75M	2.83M	4M	6.06M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	981.83K	1.53M	-601.01K	-613.91K
Other Long-Term Assets	n/a	n/a	455K	455K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	308.24K	371.6K	349.44K	389.5K
Total Current Assets	4.06M	3.2M	4.78M	6.46M
Property-Plant & Equipment	n/a	n/a	244.42K	304.36K
Goodwill & Intangibles	3.35K	3.91K	708.45K	709.01K
Total Long-Term Assets	985.18K	1.54M	952.87K	1.01M
Total Assets	5.04M	4.74M	5.73M	7.47M
Account Payables	250.13K	127.39K	276.41K	286.19K
Deferred Revenue	n/a	n/a	n/a	2.38M
Short-Term Debt	n/a	n/a	56.83K	n/a
Other Current Liabilities	453.52K	104.32K	1.02M	1.87M
Total Current Liabilities	975.86K	653.08K	1.79M	2.72M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	0.00	492K	1.01M
Total Long-Term Liabilities	n/a	437.00	665.44K	1.24M
Total Liabilities	975.86K	653.08K	2.46M	3.97M
Total Debt	n/a	n/a	207.38K	256.96K
Book Value	n/a	n/a	n/a	n/a
Book Value Per Share	n/a	n/a	n/a	n/a
Common Stock	6.47K	1.66K	26.69K	20.95K
Retained Earnings	-82M	-68.8M	-63.67M	-50.94M
Comprehensive Income	n/a	n/a	0.00	-0.00
Shareholders Equity	4.07M	4.08M	3.28M	3.51M
Total Investments	981.83K	1.53M	-601.01K	-613.91K